Form 4: Heartflow CEO John Farquhar Trades Shares
Statement of Changes in Beneficial Ownership
Heartflow, Inc. CEO John Farquhar reported a transaction involving common stock, executed under a pre-arranged trading plan.
Summary
- John C.M. Farquhar, Chief Executive Officer and Director of Heartflow, Inc., reported a transaction on June 24, 2026.
- The transaction involved the acquisition of 38,900 shares of common stock at a price of $35 per share.
- Following this transaction, Farquhar beneficially owns 457,935 shares of common stock.
- This transaction was executed as part of a Rule 10b5-1 trading plan adopted on September 12, 2025.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing. While it involves a significant transaction by the CEO, it was executed under a pre-established trading plan, mitigating immediate concerns about insider selling pressure.
Positives
- The transaction was conducted under a Rule 10b5-1 trading plan, indicating pre-planned and potentially less market-sensitive activity.
- The CEO continues to hold a significant number of shares (457,935) after the transaction.
Negatives
- The sale of 38,900 shares by the CEO could be interpreted negatively by the market, despite being part of a plan.
Risks
- The filing does not explicitly mention any risks associated with this specific transaction.
- General market risks for Heartflow, Inc. (HTFL) are not detailed in this Form 4.
Future Outlook
The filing itself is a historical record of a transaction and does not contain forward-looking statements or guidance regarding the company's future performance.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The execution of a Rule 10b5-1 plan by a CEO is a common practice to diversify holdings or manage personal finances while adhering to insider trading regulations. The specific price and volume of this transaction will be evaluated by investors in the context of Heartflow's (HTFL) current market price and overall financial health.
Stakeholder Impact
- Shareholders: May view the CEO's transaction as a routine execution of a trading plan, but some may scrutinize the sale of shares.
- Employees: The transaction is unlikely to have a direct impact on employees, but it reflects ongoing executive financial management.
- Creditors/Suppliers: No direct impact expected from this insider transaction.
Next Steps
- Investors will monitor future Form 4 filings for any additional insider transactions.
- Further analysis of Heartflow's (HTFL) financial performance and strategic updates will be necessary to contextualize this transaction.
Key Dates
| Date | Description |
|---|---|
| 09/12/2025 | Date Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| 06/24/2026 | Transaction Date for the acquisition of common stock. |
| 06/26/2026 | Date the Form 4 was signed. |
Keywords
Heartflow, HTFL, Form 4, Insider Trading, SEC Filing, Common Stock, CEO, Trading Plan, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.